Given these limitations, we chose not to rely on BMI but instead adjusted for well-established clinical indicators of obesity, such as diabetes, hypertension, hyperlipidemia, insulin use, and the Charlson Comorbidity Index (CCI). The gene discussed is INS; the disease is hyperlipidemia.